Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Meek Insider Profile
4 Followers
David Meek, EVP and President, Oncology at Baxalta Incorporated, holds 2.51K shares in uniQure (Ticker: QURE), holds 24.28K shares in Baxalta Incorporated (Ticker: BXLT), holds ― shares in Entasis Therapeutics Holdings (Ticker: ETTX). Most recently, David Meek Sold ― shares of uniQure on Jan 30, 2020 for an estimated value of 44.90K.
David Meek Baxalta Incorporated (BXLT)EVP and President, Oncology
Baxalta Incorporated (BXLT)
EVP and President, Oncology
Ranked #28,269 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+34.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Meek holds in companies
Most Profitable Insider Trade
Stock:
Endocyte
(ECYT)
(ECYT)
Rating:Informative Sell
Date:Sep 16, 2013 - Sep 16, 2014
Return:+49.00%
The most profitable trade made by David Meek
David Meek's Trading History
Baxalta Incorporated
Jun 07, 2016
―
Uninformative Sell
―
$1.12M
uniQure
Jan 30, 2020
Director
Informative Sell
44.90K
$118.50K
Entasis Therapeutics Holdings
―
Director
―
―
Endocyte
Feb 10, 2014
―
Uninformative Buy
―
$179.93K
List of latest transactions for each holding click on a transaction to see David Meek's performance on stock
You May Also Like
David Meek insider profile FAQ
What is the percentage of profitable transactions made by David Meek?
The percentage of profitable transactions made by David Meek is 100%.
What is the average return per transaction made by David Meek?
The average return per transaction made by David Meek is 34.60%.
What stocks does David Meek hold?
David Meek holds: BXLT, QURE, ETTX, ECYT stocks.
What was David Meek’s latest transaction?
David Meek latest transaction was an Informative Sell of $44.90K.
What was David Meek's most profitable transaction?
David Meek’s most profitable transaction was an Informative Sell of ECYT stock on September 16, 2013. The return on the trade was 49.00%.
What is David Meek's role in Baxalta Incorporated?
David Meek's role in Baxalta Incorporated is EVP and President, Oncology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.